Records containing: Smoldering Plasma Cell Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-21Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma (ORIGIN Study)
-
CLINICAL_TRIALS study record update · 2026-04-17Iberdomide in Intermediate- and High-Risk Smoldering Myeloma (SMM) Patients: A Phase 2 Study With a Safety Run-in
-
CLINICAL_TRIALS study record update · 2026-04-15Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
-
CLINICAL_TRIALS study record update · 2026-04-15Phase II Trial of Isatuximab (SAR650984) With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)
-
CLINICAL_TRIALS study record update · 2026-04-03Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-05Phase 2 Trial of Leflunomide in African-American and European-American Patients With High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-01-05Pilot Trial of Leflunomide in Patients With High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-19A Personalized Vaccine for the Immune Prevention of Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-01Improving Host Factors in Patients With Monoclonal Gammopathies and Other Hematologic Disorders
-
CLINICAL_TRIALS study record update · 2025-08-20Evaluating Mechanisms of Immunomodulator Sensitivity and Resistance in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2020-03-25Phase I/II Double Blind Randomized Trial of Lenalidomide/Dexamethasone/Anakinra vs. Lenalidomide/Dexamethasone/Placebo in Patients With Early Stage Multiple Myeloma and High Plasma Cell Growth Rate
-
CLINICAL_TRIALS study record update · 2020-03-20Pilot Single Arm, Single Center, Open Label Trial of Pembrolizumab in Patients With Intermediate and High Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2019-11-14Phase 2 Trial of Leflunomide in Patients With High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-03-09A Phase I-II Study of Infusional Melphalan + Bortezomib for Myeloablative Therapy Prior to Autologous Transplant for Patients With Multiple Myeloma